PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 18, 2026Respirology Case Reports0 citationsOpen Access

A Rare Case of Anti‐Yo Antibody Positive Paraneoplastic Neurologic Syndromes With EGFR Mutation Positive Non‐Small Cell Lung Cancer

View Full Paper
NONobuhiro OkagakiMUMasakuni UeyamaSFShoko Fujimoto

Key Points

  • To describe a rare case of anti-Yo antibody positive paraneoplastic neurologic syndromes in the context of EGFR mutation-positive non-small cell lung cancer.
  • Case report of a 74-year-old male with acute vertigo and cerebellar ataxia.
  • Transbronchial biopsy confirmed papillary adenocarcinoma with EGFR mutation.
  • Brain MRI and cerebrospinal fluid cytology were performed to assess for metastases and malignancy.
  • Anti-Yo antibody was positive in the patient.
  • Brain MRI showed multiple metastases.
  • After discontinuing chemotherapy due to interstitial lung disease, steroid therapy led to modest improvement in ataxic symptoms.

Abstract

ABSTRACT Paraneoplastic neurologic syndromes (PNS) associated with anti‐Yo antibody typically occur in females with ovarian or breast cancer, and their occurrence in lung cancer is rare. We report the first case of anti‐Yo antibody positive PNS in a patient with EGFR mutation‐positive non‐small cell lung cancer (NSCLC). A 74‐year‐old male presented with acute vertigo and progressive cerebellar ataxia. Anti‐Yo antibody was positive, and transbronchial biopsy confirmed papillary adenocarcinoma with EGFR exon 21 L858R mutation. Brain MRI also revealed multiple metastases, and cerebrospinal fluid cytology was positive for malignant cells. Despite the presence of brain metastases and leptomeningeal metastasis, neurological symptoms were attributed primarily to anti‐Yo PNS based on clinical presentation. Chemotherapy was discontinued due to interstitial lung disease, but subsequent steroid therapy resulted in modest improvement of ataxic symptoms. This case suggests that NSCLC presenting with anti‐Yo PNS may harbour EGFR mutations.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Okagaki et al. (2026) studied this question.

synapsesocial.com/papers/69ba428e4e9516ffd37a2ebdhttps://doi.org/10.1002/rcr2.70560
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Paraneoplastic cerebellar degeneration with anti‐Yo antibodies – a review2016 · 119 citations
  2. 2Purkinje Cell Cytoplasmic Autoantibody Type 1 Accompaniments2011 · 108 citations
  3. 3Anti-Zic4 paraneoplastic cerebellar degeneration in a patient with EGFR-mutated NSCLC: a case report2022 · 8 citations
  4. 4Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes2021 · 743 citations
  5. 5Paraneoplastic Neurologic Syndrome in the PNS Euronetwork Database2010 · 372 citations